Alison Bladh

NOVEMBER 22, 2024

As women navigate perimenopause and menopause, hormonal shifts often bring a range of challenging physical and emotional symptoms. One critical hormone in this transition is cortisol, often called the "stress hormone." While cortisol plays an essential role in our body’s natural functions, its interplay with oestrogen and progesterone during menopause can exacerbate stress and discomfort.

Management 64

Management Diet Hydration Clinic 64

The Dermatology Digest

NOVEMBER 22, 2024

Christopher Sayed, MD, a Dermatologist at the University of North Carolina Chapel Hill’s HS Clinic in Durham, NC, discusses the role that bimekizumab-bkzx may play for adults with moderate-to-severe hidradenitis suppurativa (HS) now that it has the U.S. Food and Drug Administration’s nod for this chronic inflammatory skin condition. The post What Does the Approval of Bimekizumab-bkzx (Bimzelx, UCB) Mean for the HS Community?

Clinic 78

Clinic Dermatology 78

Beauty Launchpad

NOVEMBER 22, 2024

A new YouGov poll reveals the personal factors that shape U.S. consumers hair care choices.

75

75

Dermatology Times

NOVEMBER 22, 2024

Researchers found the TYK2 inhibitor deucravacitinib offers superior efficacy to apremilast and comparable outcomes to biologics.

Therapy 73

Therapy 73

Beauty Launchpad

NOVEMBER 22, 2024

Marylle Koken, renowned Sebastian Top International Artist, iconic celebrity stylist and well-established salon owner, has been named Sebastian Professional’s Los Angeles Creative Ambassador.

Salon 52

Salon 52

Dermatology Times

NOVEMBER 22, 2024

Christopher Bunick, MD, PhD, discusses the multifactorial nature of chronic hand eczema, the burden of severe symptoms, and how delgocitinib restores skin integrity by targeting JAK/STAT pathways.

Eczema 73

Eczema 73

Dermatology Times

NOVEMBER 22, 2024

The LIBERO study confirmed brodalumab is effective in managing psoriasis in patients over 100 kg, showing comparable long-term benefits in patients under 100 kg.

Management 41

Management 41

The Dermatology Digest

NOVEMBER 22, 2024

The 2024 Cosmetic Executive Women (CEW) Beauty Awards winners are… The 2024 Beauty Awards winners include: Acne: CeraVe Acne Foaming Cream Wash Base & Complexion: Drunk Elephant B-Goldi Bright Drops Body Moisturizer/Treatment: Dermalogica Clarifying Bacne Spray Body Wash/Scrub: La Roche-Posay Lipikar AP+ Gentle Foaming Cleansing Oil Eye/Brow Product (Makeup): Clinique High Impact High-Fi Full Volume Mascara Eye/Brow Treatment (Skin): Shiseido Benefiance Wrinkle Smoothing Eye Cream Facial Cle

Makeup 36

Makeup Tools Facials Hydration 36

Dermatology Times

NOVEMBER 22, 2024

Andrea Rosik, MS, PA-C, provides insights into managing challenging cases of atopic dermatitis.

Dermatitis 41

Dermatitis Treatments Management 41

Dermatology Times

NOVEMBER 22, 2024

Pediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.

41

41

Dermatology Times

NOVEMBER 22, 2024

These findings further suggest the implications of acne vulgaris treatment on the skin barrier.

Sebum 37

Sebum Hydration Treatments 37

Dermatology Times

NOVEMBER 22, 2024

Panelists discuss how age restrictions for PDE4 inhibitors affect treatment decisions for pediatric patients with atopic dermatitis, addressing parental concerns and highlighting the benefits of a single treatment option like roflumilast for managing overlapping inflammatory dermatologic conditions; they also explore current guidelines for corticosteroid use, the potential impact of PDE4 inhibitors on these guidelines, and the future of topical PDE4 inhibitors in dermatology, including the integ

Dermatitis 36

Dermatitis Education Management Dermatology 36

Dermatology Times

NOVEMBER 22, 2024

Review insights from a premier dermatology event with expert sessions, hands-on insights, and networking to elevate clinical practice.

Networking 36

Networking Clinic Dermatology 36

Dermatology Times

NOVEMBER 22, 2024

Panelists discuss how age restrictions for PDE4 inhibitors affect treatment decisions for pediatric patients with atopic dermatitis, addressing parental concerns and highlighting the benefits of a single treatment option like roflumilast for managing overlapping inflammatory dermatologic conditions; they also explore current guidelines for corticosteroid use, the potential impact of PDE4 inhibitors on these guidelines, and the future of topical PDE4 inhibitors in dermatology, including the integ

Education 36

Education Therapy Dermatitis Management 36